Origin
|
: Prepared by enzymatic hydrolysis of N-Acetylneuraminic Acid, and purified by crystallization.
|
Formula
|
: C8H15NO6 • H2O (MW : 239.2)
|
Appearance
|
: White amorphous powder
|
Purity
|
: More than 99% by HPLC. Homogeneous by thin layer chromatographic analysis.
|
Storage
|
: Stable when stored on desiccated condition at 5oC.
|
References
|
: 1) K. Hotta, M. Kurokawa and S. Isaka, Seikagaku (in Japanese), 45 (10), 911-915 (1973)
2) S. Blayer, J. M. Woodley, M. J. Dawson and M. D. Lilly, Biotechnology and Bioengineering, 66 (2), 131-136 (1999)
|
Origin
|
: Prepared by chemo-enzymatic synthesis from glucosamine and pyruvic acid.
|
Formula
|
: C11H19NO10 (MW : 325.27 )
|
Appearance
|
: White crystalline powder
|
Purity
|
: More than 98% by HPLC
|
Storage
|
: Stable when stored on desiccated condition below -20C.
|
Origin
|
: Prepared by chemical synthesis from N-acetylneuraminic acid.
Purified by column chromatography and crystallization.
|
Formula
|
: C11H17NO8 (MW : 291.25 )
|
Appearance
|
: White crystalline powder
|
Purity
|
: More than 95% by HPLC
|
Use
|
: Neuraminidase (sialidase) inhibitor
|
Storage
|
: Stable when stored on desiccated condition at -20C.
|
Origin
|
: Prepared by enzymatic hydrolysis of Colominic Acid1), or enzymatic synthesis from N-Acetylglucosamine and Pyruvic Acid.2)
Purified by ion-exchange column chromatography and crystallization.
|
Formula
|
: C11H19NO9 (MW : 309.27)
|
Appearance
|
: White crystalline powder
|
Purity
|
: More than 99% by colorimetric determination and HPLC
|
Use
|
: Authentic specimen of the highest purity, substrate for NANA Aldolase and starting material for preparing NANA derivatives.
|
Storage
|
: Stable for one year when stored on desiccated condition at 5oC.
|
References
|
: 1) Y. Uchida, Y. Tsukada and T. Sugimori, Biochim. Biophys. Acta., 350, 425 (1974)
2) I. Maru, J. Ohnishi, Y. Ohta, and Y. Tsukada, Carbohydr. Res., 306, 575 (1998)
|
Origin
|
: Prepared by hydrolysis of Colominic Acid.
|
Formula
|
: trimer (DP3) ... C33H50N3O25Na3 (MW : 957.73)
tetramer (DP4) ... C44H66N4O33Na4 (MW : 1270.97) pentamer (DP5) ... C55H82N5O41Na5 (MW : 1584.21) hexamer (DP6) ... C66H98N6O49Na6 (MW : 1897.45) |
Appearance
|
: White amorphous powder , lyophilized
|
Purity
|
: More than 95% by HPLC
|
Storage
|
: Store below -20°C
|
Pakaging Size | : DP3: 25 mg / DP4 - DP5 : each 5 mg , 25 mg / DP6: 25 mg |
Origin
|
: Prepared by enzymatic synthesis from N-Acetylneuraminic Acid and CTP.
Purified by ion-exchange column chromatography and lyophilization.
|
Formula
|
: C20H29N4O16PNa2 (MW : 658)
|
Appearance
|
: White lyophilized powder
|
Purity
|
: More than 97% by HPLC
|
Storage
|
: Stable when stored on desiccated condition below -20oC.
|
Formula
|
: C15H19N2O18P2Na3 (MW : 646.3)
|
Appearance
|
: White crystalline powder
|
Purity
|
: More than 98% (Moisture : approx. 12%)
|
Storage
|
: Stable when stored on desiccated condition at 5oC.
|
>> Click here for ordering information.